Implementing VTE Prevention in Ambulatory Cancer Care
Part of paid clinical trials in Burlington, Vermont.
- Sponsor
- University of Vermont
- Study ID
- NCT07292376
- Status
- Enrolling By Invitation
Conditions
- Neoplasms
- Venous Thromboembolism
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Clinical program — OTHERRevised Vermont Model clinical program, including standardized education and training for oncology care team, clinical decision support and revised workflow for VTE risk assessment and thromboprophylaxis.
Study Details
assess effectiveness of a , compared with usual care, to assess The goal of this study is to learn if a modified clinical program can improve adherence to guideline recommendations for prevention of venous thromboembolism in ambulatory patients with cancer. The main question\[s\] it aims to answer are: Does the modified program improve number of ambulatory oncology patients starting systemic treatment getting VTE risk-assessment? Does the modified program improve the number of patients receiving appropriate preventative anticoagulation? Researchers will compare to usual care (no clinical program). Participant clinicians will be asked to * receive education about VTE prevention recommendations * carry out risk assessment, anticoagulation discussions, and document the results Participant patients will receive care from clinicians participating in the study as part of their cancer care.
Key Dates
- Start date
- Oct 1, 2025
- Status verified
- Dec 2025
- Primary completion
- Apr 30, 2026
- Completion
- Jul 30, 2026
Study Design
- Enrollment
- 25 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- OTHER
Arms
- Other: Clinical program
Primary Outcome Measure
Documented VTE risk assessment [ Time Frame: 30 days after new patient appointment ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Vermont Health | Burlington | Vermont | 05405 | - |
Find similar trials in Burlington, VT
Related Studies
- Venous Thromboembolism Prevention in Outpatients With GliomaPHASE2 · Recruiting · University of Vermont Medical Center · Burlington, Vermont
- Collection of Tissue Specimens From Patients With Solid Tumors or Blood Disorders and Their HLA-Compatible Family MembersRecruiting · National Heart, Lung, and Blood Institute (NHLBI) · Bethesda, Maryland
- Novel Serum Markers for Monitoring Response to Anti-Cancer TherapyRecruiting · Stanford University · Stanford, California
- Barrett's Esophagus Related Neoplasia (BERN) ProjectRecruiting · Midwest Biomedical Research Foundation · Kansas City, Missouri